In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 and Cardiology

Resource library and new ESC Video Series.

Access now

2019 Guidelines on Supraventricular Tachycardia (for the management of patients with)

ESC Clinical Practice Guidelines

Arrhythmias, General
Atrial Fibrillation
Supraventricular Tachycardia (non-AF)
Guidelines version available to download
Published in 2019
Published in 2019
Published in 2019
Published in 2019
Reference PG TOC
Published in 2019
Reference 2019 Slides on SVT
Published in 2019
Published in 2019
Reference CME
Published in 2019
Reference Pocket Guidelines App
Table of contents: Full Text (ESC Clinical Practice Guidelines)
  • Preamble
  • Introduction
    • Evidence review
    • Relationship with industry and other conflicts of interest
    • What is new in the 2019 Guidelines?
  • Definition and lcassification
  • Electrophysiological mechanisms of supraventricular tachycardia
  • Cardiac anatomy for the electrophysiologist
  • Epidemiology of supraventricular tachycardia
  • Clinical presentation
  • Initial evaluation of patients with supraventrcular tachycardia
  • Differential diagnosis of tachycardia
    • Narrow QRS (=120ms) tachycardia
      • Electrocardiographic differential diagnosis
      • Vagal manoeuvres and adenosine
      • Electrophysiology study
    • Wide QRS (>120ms) tachycardia
      • Electrocardiographic differential diagnosis
      • Electrophysiology study
    • Irregular tachycardia
  • Specific types of supraventricular tachycardia
    • Atrial arrhythmias
      • Sinus tachydardia
      • Focal atrial tachycardia
      • Multifocal atrial tachycardia
      • Maro-re-entrant atrial tachycardia
    • Atrioventricular junctional arrhythmias
      • Atrialventricular modal re-entrant tachycardia
      • Non-re-entrant junctional tachycardia
    • Atrioventricular arrhythmia
      • Accessory pathways
      • Wolff Parkinson White syndrome
      • Orthodromic atrioventricular re-entrant tachycardia
      • Antidromic atrioventricular re-entrant tachycardia
      • Accessory pathway as a bystander
      • Pre-excited atrial fibrillation
      • Concealed accessory pathways
      • Permanent junctional reciprocating tachycardia
      • Atypical forms of pre-excitation (Mahaim fibres)
  • Supraventricular tachycardia in adults with congenital heart disease
    • Pharmacopological antiarrhythmic therapy
    • Catheter and surgical ablation
    • Specific disease states
      • Atrial septal defect
      • Ebstein's anomaly
      • Transposition of the great arteries
      • Tetralogy of Fallot
      • Fontan repairs
  • Supraventricular tacycardia in the paediatric population
    • Foetal arrhythmias
  • Supraventricular tachycardia in pregnancy
    • Material obstretic and offspring risk
    • Therapy
      • Antiarrhythmic drugs
      • Electrical cardioversion
      • Catheter ablation
  • Tachycardia-induced cardiomyopathy
    • Definition
    • Mechanism
    • Diagnosis
    • Therapy
  • Supraventricular tachycardia in sports
  • Supraventricular tachycardia and driving restrictions
  • Key messages
  • Gaps in evidence
  • Evidence-based "what to do" and 'what not to do" messages from the Guidelines
  • Supplementary data
  • Appendix
  • References
Previous version available to download
Published in 2003
Reference ESC Web Site only
Published in 2003
Reference EHJ 2003;24:1857-1897
Published in 2003
Reference SVA